✦ LIBER ✦

Rationale for Selective COMT Inhibitors as Adjuncts in the Drug Treatment of Parkinson's Disease

✍ Scribed by Männistö, P. T. ;Kaakkola, S.

Book ID: 114801441
Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 684 KB
Volume: 66
Category: Article
ISSN: 0901-9928
DOI: 10.1111/j.1600-0773.1990.tb00756.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ropinirole as an adjunct to levodopa in

Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease

✍ Joo-Hyuk Im; Jeong-Ho Ha; In-Sook Cho; Myoung C. Lee 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 206 KB

Ropinirole as an adjunct to levodopa in

Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease

✍ N. P. Quinn 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 92 KB

Rationale for the use of dopamine agonis

Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease

✍ Anthony H. V. Schapira; C. Warren Olanow 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Quetiapine for the treatment of drug-ind

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

✍ Hubert H. Fernandez; Joseph H. Friedman; Carol Jacques; Michael Rosenfeld 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 2 views

QUETIAPINE FOR THE TREATMENT OF DRUG-IND

QUETIAPINE FOR THE TREATMENT OF DRUG-INDUCED PSYCHOSIS IN PARKINSON's DISEASE

✍ Fernandez, Hubert H.; Friedman, Joseph H.; Rosenfeld, Michael; Jacques, Carol; C 📂 Article 📅 1999 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 56 KB

Efficacy and safety of opicapone, a new

Efficacy and safety of opicapone, a new COMT-inhibitor, for the treatment of motor fluctuations in Parkinson's Disease patients: BIPARK-II study

✍ Lees, A.; Ferreira, J.J.; Costa, R.; Rocha, J.-F.; Oliveira, C.; Lopes, N.; Nune 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB